Atea Pharmaceuticals (NASDAQ:AVIR) Upgraded to “Hold” at Wall Street Zen
Wall Street Zen upgraded shares of Atea Pharmaceuticals (NASDAQ:AVIR – Free Report) from a sell rating to a hold rating in a report issued on Thursday. A number of other research analysts have also weighed in on the company. William Blair restated an “outperform” rating on shares of Atea Pharmaceuticals in a report on Friday, […]
Wall Street Zen upgraded shares of Atea Pharmaceuticals (NASDAQ:AVIR – Free Report) from a sell rating to a hold rating in a report issued on Thursday. A number of other research analysts have also weighed in on the company. William Blair restated an “outperform” rating on shares of Atea Pharmaceuticals in a report on Friday, […]
